Global investors who bought private shares ahead of its suspended initial public offering ,including Boston-based Fidelity Investments, cut its estimate for Ant to $70 billion at the end of May. That’s down from $78 billion in June last year, and $235 billion just before Ant’s IPO was torpedoed by regulators in November 2020.